David Chernoff, MD

Chief Medical Officer | Setpoint Medical

David Chernoff has 25 years of molecular diagnostics and biopharmaceutical experience and has served as a translational medicine consultant to more than 40 biopharma and device companies. He has held chief medical officer posts with a number of venture capital backed diagnostic and therapeutic companies. He was formerly VP of Corp Technology at Elan Pharma and Medical Director at Chiron Corp.

All Sessions by David Chernoff, MD

  • October 18, 2023


  • 11:15 AM  - 11:55 AM
    Neuromodulation technologies have elicited strong expectations from investors. As products begin to close on commercial stages, companies are finding ways to work with physicians and patients to ensure these new tools can deliver. In this panel three executives from leaders in the space will share how they’re moving to build out the market for neuromodulation technologies.
    Bringing Devices to Market
    Where
    Room 210




Share

David Chernoff, MD